Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT01363596 · ClinicalTrials.gov registry record
International NaProTechnology Evaluation and Surveillance of Treatment for Infertility and Miscarriage (iNEST)
A clinical trial, sponsored by University of Utah.
- Completed
- Registry status
- 834
- Enrollment target
NCT01363596: Completed study, sponsored by University of Utah.
NCT01363596 is a clinical trial that has completed, run by University of Utah. The registered enrollment target is 834 participants. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT01363596 has completed, sponsored by University of Utah.
- COMPLETED
- Registry status
- 834 participants
- Enrollment target
Study Summary
NaProTechnology (NPT) is a treatment option for infertility or miscarriage that identifies issues in a couple's fertility and fixes them to the extent possible by medical intervention. An important part of NPT is teaching couples to monitor the signs and symptoms of the woman's fertility cycle (menstrual cycle) with the Creighton Model FertilityCare System (CrMS). The purpose of the study is to look at outcomes among couples who consider or get NPT treatment to help them have a live birth. Results from the study will be used to answer questions such as: How many couples who use NPT get pregnant and have a baby? How can NPT treatment be improved? Does NPT treatment have fewer long-term health risks for the resulting children than other fertility treatments? What types of characteristics or environmental exposures influence whether NPT will be successful for a specific couple? To be eligible for the iNEST study, a couple must have a consultation with a NPT-trained clinician who is participating in iNEST.
Primary Outcome
The main outcome of this study is the proportion of subjects that had a live birth at various time points up to three years after beginning treatment with NPT, compared to couples who do not receive NPT treatment, or who cease to receive NPT treatment.
Interventions
- OTHER Creighton Model System in conjunction with Natural Procreative Technology (NPT)
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 834 participants |
| Start Date | 2006-01 |
| Est. Completion | 2020-12 |
What the finished NCT01363596 record still lists
NCT01363596 is an observational study that tracks outcomes without assigning an intervention. The registered 834 participants enrollment target is mid-sized for trials with a published cap.
The record links to 0 conditions, and to 1 intervention - of which Creighton Model System in conjunction with Natural Procreative Technology (NPT) is the first listed.
NCT01363596 does not publish any study locations in the registry export this page uses.
Frequently Asked Questions
What is clinical trial NCT01363596 about?
NCT01363596 is a clinical study titled "International NaProTechnology Evaluation and Surveillance of Treatment for Infertility and Miscarriage (iNEST)". NaProTechnology (NPT) is a treatment option for infertility or miscarriage that identifies issues in a couple's fertility and fixes them to the extent possible by medical intervention. An important part of NPT is teaching couples to monitor the signs and symptoms of the woman's fertility cycle (mens...
What is the current status of trial NCT01363596?
This trial is currently completed. The enrollment target is 834 participants. The study started on 2006-01. Estimated completion is 2020-12.
What interventions are being tested in trial NCT01363596?
The interventions under investigation include: Creighton Model System in conjunction with Natural Procreative Technology (NPT) (OTHER).
Who is sponsoring clinical trial NCT01363596?
This trial is sponsored by University of Utah, which has 818 total clinical trials registered on ClinicalTrials.gov.
Learn More About Clinical Trials
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT03670524 · 835 participants · NA
Health, Environment and Action in Louisville (HEAL) Green Heart Louisville Project
- NCT02118467 · 836 participants · Phase 4
Vasoactive Drugs in Intensive Care Unit
- NCT06910553 · 832 participants
IBD Pregnancy Registry
- NCT07089706 · 832 participants · Phase 4
A Study to Evaluate the Immunogenicity and Safety of mRNA-1283 COVID-19 Variant-containing Formulations
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia